Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00216112
Status:
COMPLETED
Last Update Posted:
2016-02-19
First Post:
2005-09-12
Brief Title:
Imatinib Mesylate in Combination With Docetaxel for Advanced Platinum-Refractory Ovarian Cancer
Sponsor:
Daniela Matei MD
Organization:
Hoosier Cancer Research Network
Organization Data
Organization:
Hoosier Cancer Research Network
Class:
OTHER
Study ID:
HOG GYN 03-62
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Daniela Matei MD
Lead Sponsor Class:
OTHER
Responsible Party:
Daniela Matei MD
Responsible Party Title:
Sponsor-Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Hoosier Cancer Research Network
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Walther Cancer Institute | OTHER |
| Novartis Pharmaceuticals | INDUSTRY |
| Sanofi | INDUSTRY |